DDAVP Therapy Controls Bleeding in Ehlers-Danlos Syndrome
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
PURPOSE: Patients with Ehlers-Danlos syndrome (EDS), especially types IV, VI, and VIII, are at increased risk of bleeding, and most do not have specific hemostatic deficiencies that would be amenable to replacement therapy. We have investigated the ability of DDAVP (desmopressin acetate) to control bleeding in EDS. PATIENTS AND METHODS: Two children with EDS, types VIII and VI, presented with hemorrhagic symptoms and scheduled surgical procedures. Ivy bleeding times (BTs) were measured before and after intravenous (i.v.) DDAVP challenge, and i.v. DDAVP was used prophylactically for their procedures. Laboratory testing was performed to rule out other hemostatic disorders. RESULTS: Both patients had prolonged BTs that corrected following i.v. DDAVP therapy; all other laboratory values were normal. Both patients had excellent clinical hemostasis with surgery, and one has continued to use intranasal DDAVP to control epistaxis and gingival bleeding. CONCLUSIONS: The bleeding time in both patients was corrected with DDAVP, and the patients did not have any postoperative bleeding. DDAVP should be considered in other patients who have EDS with bleeding tendencies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International nosology of heritable disorders of connective tissue, Berlin, 1986
Beighton, P., de Paepe, A., Danks, D., Finidori, G., Gedde‐Dahl, T., Goodman, R., Hall, J. G., Hollister, D. W., Horton, W., McKusick, V. A., et al. (1988) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320290316 · Cited by 732
Ehlers-Danlos syndrome, type VIII presenting with periodontitis and prolonged bleeding time
CUNNIFF, C., & WILLIAMSON-KRUSE, L. (1995) · Clinical Dysmorphology · doi:10.1097/00019605-199504000-00006 · Cited by 28
Cited by
Bolton‐Maggs, P. H. B., Perry, D. J., Chalmers, E. A., Parapia, L. A., Wilde, J. T., Williams, M. D., Collins, P. W., Kitchen, S., Dolan, G., & Mumford, A. D. (2004) · Haemophilia · doi:10.1111/j.1365-2516.2004.00944.x · Cited by 546
Ehlers-Danlos syndrome type IV
Germain, D. P. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-32 · Cited by 376
Malfait, F., Castori, M., Francomano, C. A., Giunta, C., Kosho, T., & Byers, P. H. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0194-9 · Cited by 316
Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type
Malfait, F., Wenstrup, R. J., & De Paepe, A. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181eed412 · Cited by 293
Kosho, T., Takahashi, J., Ohashi, H., Nishimura, G., Kato, H., & Fukushima, Y. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30965 · Cited by 51
Metadata
- Authors
- Stine, K. C., & Becton, D. L.
- Venue
- Journal of Pediatric Hematology/Oncology
- Published
- 1997-03
- Volume
- 19
- Issue
- 2
- Pages
- 156-158
- ISSN
- 0192-8562 (ISSN-L)
- OpenAlex
- W2027997090
- Cited by
- 58
- References
- 2
- FWCI
- 0.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DDAVP Therapy Controls Bleeding in Ehlers-Danlos Syndrome. https://app.cochat.ai/papers/10.1097/00043426-199703000-00012
- The paper
- Stine, K. C., & Becton, D. L. (1997). DDAVP Therapy Controls Bleeding in Ehlers-Danlos Syndrome. Journal of Pediatric Hematology/Oncology. https://doi.org/10.1097/00043426-199703000-00012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.